Newsfeeds - Spark Newswire

2 minute read

Analyst Ratings

Expert Ratings for Exact Sciences

Today, 1:02 PM

Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

EXAS

2 minute read

Analyst Ratings

Raymond James Maintains Outperform Rating for Exact Sciences: Here’s What You Need To Know

By Benzinga Insights

Today, 1:02 PM

Raymond James has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $70.00 to $60.00. Shares of Exact Sciences are trading up 3.28% over the last 24 hours, at $39.41 per share.

EXAS

1 minute read

Raymond James Maintains Outperform on Exact Sciences, Lowers Price Target to $60

By Benzinga Newsdesk

Today, 1:02 PM

Raymond James analyst Andrew Cooper maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $70 to $60.

EXAS

8 minute read

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday

By Lisa Levin

Today, 1:02 PM

Gainers

6 minute read

Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 1:02 PM

Gainers

ADNT

3 minute read

Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday

By Lisa Levin

Today, 1:02 PM

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

31 minute read

Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights

Today, 1:02 PM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

AAOI

2 minute read

Cathie Wood’s Funds Deliver Mixed Q3 Results: Ark Founder’sShares Take On Zoom, Roku, Teladoc And Blockchain

By Bhavik Nair

Today, 1:02 PM

Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI World Index but under

ARKK

1 minute read

Analyst Ratings

8 Analysts Have This to Say About Exact Sciences

By Benzinga Insights

Today, 1:02 PM

Analysts have provided the following ratings for Exact Sciences (NASDAQ:EXAS) within the last quarter:

EXAS

6 minute read

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:02 PM

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

ACOR